Podcasts about antiretrovirals

  • 20PODCASTS
  • 40EPISODES
  • 18mAVG DURATION
  • ?INFREQUENT EPISODES
  • Nov 14, 2023LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about antiretrovirals

Latest podcast episodes about antiretrovirals

Buried Pleasures
HIV, Pep, & Prep Education with Christopher Hetzer RN, MSN

Buried Pleasures

Play Episode Listen Later Nov 14, 2023 43:56


Join PollyAnnamazing and her guest, viral TikTok Sexual Health Educator, Christopher Hetzer RN, MSN, as they discuss the ever evolving landscape HIV treatments.  Check out our conversations on the use of the antiretrovirals PEP and PrEP. This is Part 1 of a memorable conversation regarding responsible sex education and treatment for all humans so don't forget to  jump on board with Buried Pleaseures ! 

Breakpoints
#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?

Breakpoints

Play Episode Listen Later Apr 28, 2023 57:32


Episode Notes Drs. Emily Kirkpatrick, Paul Sax, and Jill Strayer join Dr. Rachel Britt to discuss their experiences using injectable long-acting antiretrovirals, especially cabotegravir/rilpivirine, in their clinics. Listen to learn not only about logistical challenges with these drugs, but also creative solutions to overcome them. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/ Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, Stitcher, Google Play, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/ Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.

JAMA Editors' Summary: On research in medicine, science, & clinical practice. For physicians, researchers, & clinicians.
Rapid-Onset Opioid vs Neuromuscular Blocker for Rapid Sequence Intubation, 180-Day Outcomes in COVID-19 in REMAP-CAP, Recommendations for Antiretrovirals for Treatment and Prevention of HIV, and more

JAMA Editors' Summary: On research in medicine, science, & clinical practice. For physicians, researchers, & clinicians.

Play Episode Listen Later Jan 3, 2023 15:28


Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 3, 2023, issue. Related Content: Audio Highlights

CCO Infectious Disease Podcast
Empowering Patients to “Age Healthy” With HIV

CCO Infectious Disease Podcast

Play Episode Listen Later Oct 12, 2022 9:28


In this episode, Cristina Mussini, MD, shares her approach to caring for aging patients with HIV. This includes not just focusing on their HIV, but their over well-being, such as:Maintaining a healthy weight, eating healthy and staying mobile Overcoming the obstacle of stigma from society and self-stigmaEmpowering patients to care for themselvesIn women who are often caregivers most of their life:Encouraging self-careStaying up to date with preventive care such as cancer screenings (eg, mammography, annual Pap smear, and colonoscopy)Teaching patients to love themselvesMaking sure the patient knows you truly care for themFaculty:Cristina Mussini, MDHead of Department of Infectious Diseases and Tropical MedicineFull Professor of Infectious DiseasesInfectious Diseases Clinics, University HospitalUniversity of Modena and Reggio EmiliaModena, ItalyLink to full program:https://bit.ly/3KkF4iZ

Falling Out LGBTQ
A Legacy of Care - Melissa Grove

Falling Out LGBTQ

Play Episode Listen Later Aug 18, 2022 66:47


legacycares.orgfallingoutlgbtq.cominstagram: @fallingoutlgbtqpodtwitter: @fallinglgbtqMelissa Grove M.S., LPC has served as Executive Director of Legacy Counseling Center, Inc. since 1999, transforming the agency into the largest provider of mental health services for HIV+ people in the South. The Grace Project National Conference for Women Living with HIV she founded hosts 200 HIV+ women annually. Other projects include founding Legacy Founders Cottage, an AIDS care facility, and creating the centralized housing solution, Homebaseforhousing.org website. Her newest program, Legacy Master Leasing, sublets apartments to homeless people living with HIV. Ms. Grove speaks around the nation on issues pertaining to mental health, relationships, muscular dystrophy, HIV and chronic illness She additionally has a private therapy practice in Dallas, TX.She was named the 2014 Public Citizen of the Year through the North Central Texas National Association of Social Workers, and received the 2015 Black Tie Dinner Kuchling Humanitarian Award. Currently Ms. Grove has served on the National Consumer Advisory Committee for the Muscular Dystrophy Association and consults on the STS4HIV Project, a project of the National Institute on Drug Abuse.

Australian Prescriber Podcast
E133 – Prescribing for patients on antiretrovirals

Australian Prescriber Podcast

Play Episode Listen Later Jun 20, 2022 22:20


Many drugs can interfere with antiretroviral therapy. Dhineli Perera chats with Yasmin Hughes, an advanced trainee in sexual health medicine, about the importance of checking potential interactions when prescribing other medicines.

patients prescribing antiretrovirals
The Future of HIV Care
The Short-Term Verdict on Long-Acting Antiretrovirals

The Future of HIV Care

Play Episode Listen Later Mar 29, 2022 33:45


We talk with Chloe Orkin, M.D., about one aspect of our future that in some very concrete ways has already arrived, and yet is currently out of reach for millions: long-acting medical interventions for HIV, the first of which were approved in the U.S. and Europe for treatment over a year ago and approved in the U.S. for prevention late last year. The beginning of the long-acting era has revealed anew some longstanding questions regarding who these drugs primarily benefit, who is able to receive them, and how our entire medical system is set up to serve -- or not serve -- the people who can most benefit from it.   Dr. Orkin is a professor of HIV medicine at Queen Mary University of London and the president of the Medical Women's Federation. She is one of world's leading minds in HIV research in medicine -- as well as one of the leading voices in conversations about health equity, access, and anti-discrimination.   Read the full transcript (clicking the link also helps support the podcast!): https://www.thebodypro.com/article/future-hiv-care-podcast-3-long-acting-antiretrovirals     Our podcast team: Episode host and executive producer Myles Helfand; audio producers/engineers Alex Portaluppi and Lucy Mueller; project manager Alina Mogollon-Volk; and podcast editors Maria Elena Perez and Juan Michael Porter II.

PVRoundup Podcast
Cancer immunotherapy might be able to reverse HIV latency

PVRoundup Podcast

Play Episode Listen Later Feb 1, 2022 3:23


Can cancer immunotherapy help cure HIV? Find out about this and more in today's PV Roundup podcast.

On a WiIM
Episode 6: Antiretrovirals with Dr. Simmons

On a WiIM

Play Episode Listen Later Dec 30, 2021 29:12


Dr. Simmons is a clinician educator in the Section of Infectious Diseases and an Associate Program Director for the Internal Medicine Residency at Boston University, who joins us to speak about antiretrovirals for HIV!

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
619: Management of Antiretrovirals in Critically Ill Patients

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Play Episode Listen Later Jun 21, 2021 3:52


Show notes at pharmacyjoe.com/episode619. In this episode, I'll discuss the management of antiretrovirals in critically ill patients. . The post 619: Management of Antiretrovirals in Critically Ill Patients appeared first on Pharmacy Joe.

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast
619: Management of Antiretrovirals in Critically Ill Patients

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Play Episode Listen Later Jun 21, 2021 3:52


Show notes at pharmacyjoe.com/episode619. In this episode, I ll discuss the management of antiretrovirals in critically ill patients. . The post 619: Management of Antiretrovirals in Critically Ill Patients appeared first on Pharmacy Joe.

Breakpoints
A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV

Breakpoints

Play Episode Listen Later Apr 16, 2021 32:10


Dr. Fidelia Bernice, Dr. Rodrigo Burgos, and Dr. Neha Pandit, join Breakpoints to discuss the first available long-acting antiretroviral agent, cabotegravir/rilpivirine. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Africa Daily
Why is Kenya short on HIV drugs?

Africa Daily

Play Episode Listen Later Apr 9, 2021 14:00


Kenya's running low on anti-HIV drugs. Antiretrovirals can be really helpful when it comes to keeping people living with HIV healthy. But for the last couple of months, they've been hard to come by in Kenya. This is partly due to a tax dispute between the government and donors who import the drugs. Health workers on the ground tell a different story though. Some say access to these life-saving drugs has been a problem for a while. So, how's this affecting the lives of the estimated 1.5- million Kenyans living with HIV? Hosted by Alan Kasujja (@Kasujja on Twitter) #AfricaDaily

PaperPlayer biorxiv neuroscience
HIV antiretrovirals have differential effects on viability and function in human iPSC-derived neurons and neural precursor cells

PaperPlayer biorxiv neuroscience

Play Episode Listen Later Sep 5, 2020


Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.09.05.284422v1?rss=1 Authors: Smith, A. S., Ankam, S., Basa, R. C. B., Gordon, K. L., Terskikh, A. V., Jordan-Sciutto, K. L., Price, J., McDonough, P. M. Abstract: Combination antiretroviral therapy (cART) improves life expectancy and lowers the incidence of central nervous system (CNS) opportunistic infections, lymphomas, and HIV-associated dementia in HIV+ people. However, mild-to-moderate HIV-associated neurocognitive disorders (HAND) persist in about 50% of HIV+ people, even when HIV replication is well controlled. In vitro, animal model, and clinical studies suggest that cART neurotoxicity could be a contributing factor to the progression of HAND. In this study, we developed two in vitro model systems using glutamatergic neurons derived from human induced pluripotent stem cells (hiPSC-Gluts) and fetal neural precursor cells (hNPCs) to assay for antiretroviral (ARV) effects on mature and developing neurons, respectively. We tested four ARVs: the nucleoside/nucleotide reverse transcriptase inhibitors tenofovir disproxil fumarate (TDF) and emtricitabine (FTC) and the integrase inhibitors dolutegravir (DTG) and elvitegravir (EVG). DTG, EVG, and TDF decreased hiPSC-Glut viability and neurite length; all four antiretrovirals decreased hiPSC-Glut synapse counts; and DTG and EVG decreased the frequency and magnitude of hiPSC-Glut calcium transients. The magnitude of these neurotoxic effects increased with longer ARV exposure times and with the exposure of hiPSC-Gluts to two or three ARVs simultaneously. These results suggest that certain ARVs could cause HAND by decreasing the survival and function of CNS neurons. In fetal hNPCs, TDF decreased viability and changed the distribution of epigenetic histone modifications, suggesting that this ARV may alter neurogenesis, which could impair cognition in adults and/or CNS development for those exposed to ARV in utero or early childhood. Our study establishes human preclinical neurotoxicity systems that can screen for potential ARV CNS toxicity and develop safer cART regimens. Copy rights belong to original authors. Visit the link for more info

ScientiaCME Podcast
HIV Prevention: The Role of Pre-Exposure Prophylaxis (PrEP)

ScientiaCME Podcast

Play Episode Listen Later Oct 16, 2019 46:58


Presented by Geeta Gupta To earn ACCME or ACPE credit, go online to scientiacme.org/cmecoursecontent.php?ID=295 to view the slides and complete the post-test. In this online CME self-learning program: The development of antiretroviral therapy (ART) has had a dramatic impact on HIV-related morbidity and mortality. The use of ART in HIV-infected patients has been the core strategy to not only treat HIV but also prevent vertical HIV transmission. Antiretrovirals can be used for HIV prevention in patients who are not HIV-infected but are repeatedly exposed to HIV in a strategy termed pre-exposure prophylaxis (PrEP). Although the rationale for PrEP stems from successful HIV prevention in HIV exposed infants with the use of ART during labor, early post-partum period, and throughout breastfeeding, it has more recently applied to been applied to sexual transmission (e.g., people with multiple partners or HIV serodiscordant couples) and people who inject drugs illicitly with support from the literature. Because much of what comprises evidence and guidelines supporting PrEP has been published relatively recently and because healthcare professionals are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice in a timely manner, continuing healthcare education activities in this area are warranted. This program is supported by an educational grant from Gilead. Faculty Disclosure: Dr. David J. Cennimo has no relevant financial relationships to disclose.  

CReATe Connect Podcast
ALS Untangled Series: Ep. 13 – Antiretrovirals

CReATe Connect Podcast

Play Episode Listen Later Dec 20, 2018 14:54


Several observations suggest that retroviruses might be able to kill motor neurons, causing forms of ALS. Here we review these data, focusing on the theory that reactivation of an "endogenous" retrovirus we all have hiding in our genes called Herv-K might cause some cases of sporadic ALS. We examine drugs that attack retroviruses as potential treatments for patients with ALS.

CReATe Connect Podcast
ALS Untangled Series: Ep. 13 – Antiretrovirals

CReATe Connect Podcast

Play Episode Listen Later Dec 20, 2018 14:54


Several observations suggest that retroviruses might be able to kill motor neurons, causing forms of ALS. Here we review these data, focusing on the theory that reactivation of an "endogenous" retrovirus we all have hiding in our genes called Herv-K might cause some cases of sporadic ALS. We examine drugs that attack retroviruses as potential treatments for patients with ALS.

Ask the Naked Scientists Podcast
Could the Earth be a living creature?

Ask the Naked Scientists Podcast

Play Episode Listen Later Sep 22, 2016 20:56


Could planet Earth be a living creature, how do they name medicines, what's the difference between a heart attack and a cardiomyopathy, how do HIV protective drugs work and how were the Egyptian pyramids built? Plus, news of a new gene that could screen for heart disease. Like this podcast? Please help us by supporting the Naked Scientists

Ask the Naked Scientists
Could the Earth be a living creature?

Ask the Naked Scientists

Play Episode Listen Later Sep 22, 2016 20:56


Could planet Earth be a living creature, how do they name medicines, what's the difference between a heart attack and a cardiomyopathy, how do HIV protective drugs work and how were the Egyptian pyramids built? Plus, news of a new gene that could screen for heart disease. Like this podcast? Please help us by supporting the Naked Scientists

The Lancet
UNAIDS Commission: The Lancet: June 25, 2015

The Lancet

Play Episode Listen Later Jun 25, 2015 16:09


Peter Piot outlines key themes and priorities emerging from The Lancet/UNAIDS Commission launched on June 25

The Lancet
The Lancet: June 14, 2013

The Lancet

Play Episode Listen Later Jun 14, 2013 14:24


Rafick-Pierre Sekaly discusses a Review about barriers to a cure for HIV.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: February 01, 2013

The Lancet Infectious Diseases

Play Episode Listen Later Feb 1, 2013 10:55


Daniela de Angelis discusses HIV incidence in England and Wales among men who have sex with men.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: March 26, 2012

The Lancet Infectious Diseases

Play Episode Listen Later Mar 26, 2012 8:44


April highlights, including discussion of a new antibiotic for C Difficile.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: January 23, 2012

The Lancet Infectious Diseases

Play Episode Listen Later Jan 23, 2012 8:44


February highlights, including discussion of HIV therapy, rotavirus, polio vaccination, and surgery for drug-resistant TB.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: July 26, 2010

The Lancet Infectious Diseases

Play Episode Listen Later Jul 26, 2010 10:55


Didier Raoult discusses optimum treatment for Q fever endocarditis.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: June 22, 2010

The Lancet Infectious Diseases

Play Episode Listen Later Jun 22, 2010 5:27


Peter Hayward discusses highlights from the July HIV themed issue.

The Lancet
The Lancet: February 12, 2010

The Lancet

Play Episode Listen Later Feb 12, 2010 12:40


An expert view on TB/HIV co-infection from Linda-Gail Bekker.

Academic OB/GYN Podcast – Academic OB/GYN
Academic OB/GYN Podcast Episode 13 – Green Journal November-December 2009

Academic OB/GYN Podcast – Academic OB/GYN

Play Episode Listen Later Dec 22, 2009


Host Nicholas Fogelson discusses articles from The Green Journal from November and December of 2009.  Topics include Flu Vaccines and Antiretrovirals in Pregnancy, HPV Vaccine Safety in Pregnancy (yes), Moxibustion for Version (crazy), and Stupid Birth Control Comparisons (Pharma gone wild) Academic OB/GYN Episode 13 – Green Journal November-December 2009

The Lancet Infectious Diseases
The Lancet Infectious Diseases: December 21, 2009

The Lancet Infectious Diseases

Play Episode Listen Later Dec 21, 2009 8:26


Discussion of public awareness campaigns to prevent inappropriate use of antibiotics.

The Lancet Oncology
The Lancet Oncology: December 01, 2009

The Lancet Oncology

Play Episode Listen Later Dec 1, 2009 8:22


Audrey Ceschia discusses issue highlights, including impact of HIV infection on cancer risk.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: September 22, 2009

The Lancet Infectious Diseases

Play Episode Listen Later Sep 22, 2009 6:33


Discussion of pandemic influenza H1N1, and antiretroviral therapy in low-income and middle-income countries.

The Lancet
The Lancet: July 24, 2009

The Lancet

Play Episode Listen Later Jul 24, 2009 11:02


July 24: experts review the International AIDS Society meeting.

The Lancet
The Lancet: July 24, 2009

The Lancet

Play Episode Listen Later Jul 24, 2009 15:26


Discussion of the malaria Special Report, and news from the International AIDS Society meeting in South Africa.

The Lancet
The Lancet: June 19, 2009

The Lancet

Play Episode Listen Later Jun 19, 2009 17:39


Discussion of the WHO Maximising Positive Synergies report concerning global health initiatives and health systems.

The Lancet
The Lancet: August 22, 2008

The Lancet

Play Episode Listen Later Aug 22, 2008 11:37


Laurent Lantieri discusses successful facial transplantation of a man with severe neurofibroma.

The Lancet
The Lancet: August 08, 2008

The Lancet

Play Episode Listen Later Aug 8, 2008 14:42


Chants from HIV activists, the launch of The Lancet HIV prevention series, and the voice of a former US President: a round-up of audio highlights from the XVII World AIDS meeting in Mexico City.

The Lancet
The Lancet: July 25, 2008

The Lancet

Play Episode Listen Later Jul 25, 2008 20:16


Pam Das and Sally Hargreaves discuss highlights from the July 26 issue of The Lancet and the August issue of The Lancet Infectious Diseases ahead of the World AIDS meeting in Mexico next month.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: July 25, 2008

The Lancet Infectious Diseases

Play Episode Listen Later Jul 25, 2008 19:39


Pam Das and Sally Hargreaves discuss highlights from the August issue of The Lancet Infectious Diseases ahead of the World AIDS meeting in Mexico next month.

The Lancet
The Lancet: April 06, 2007

The Lancet

Play Episode Listen Later Apr 6, 2007 9:06


Dr Erika Sims from the University of East Anglia, UK, discusses the research article in this week's issue showing how newborn screening for cystic fibrosis is justifiable in economic terms, building on previous evidence showing the clinical value of newborn screening.

The Lancet Infectious Diseases
The Lancet Infectious Diseases: October 26, 2006

The Lancet Infectious Diseases

Play Episode Listen Later Oct 26, 2006 4:22


Pam Das And Richard Lane discuss the highlights from the November issue. The topics covered include treatment standards for tuberculosis, future possibilities for a vaccine against diseases caused by worm infestations.